Back to search

Article

Polymerase I as a Target for Treating Neurodegenerative Disorders

2024-04-04

Abstract excerpt

Polymerase I (Pol I) is at the epicenter of ribosomal RNA (rRNA) synthesis. Pol I is a target for treatment of cancer. Given the many cellular commonalities between cancer and neurodegeneration (i.e., different faces of the same coin) it seems rational to consider targeting of Pol I or, more generally, rRNA synthesis for treatment of disorders associated with the death of terminally differentiated neurons. Princip...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
20b462d6-7bba-5499-83c3-5e4c3eaa4ae3
DOI
10.20944/preprints202404.0322.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Polymerase I as a Target for Treating Neurodegenerative DisordersDOI 10.20944/preprints202404.0322.v1
Select a neighboring publication to make it the new centre.